Showcase
Menu

RELIEF PLUS / EVIDENCE

EVIDENCE

Evidence is not one document.
It is a connected body of work.

Scientific development, research, validation, regulatory status, organisational records, and intellectual property each establish something different.

This section explains what each form of evidence supports—and where its limits remain.

Evidence with boundaries

Validation is not one certificate or one study.

RELIEF PLUS brings together a scientific assessment programme, a regulated digital product, registered organisations, and protected intellectual property. These forms of credibility answer different questions and should not be presented as interchangeable.

This section separates what has been published, what remains under development, what a licence authorises, and what an organisational or intellectual-property record actually establishes.

Evidence map

Six places to examine the evidence

Move from the scientific model to published research, the development pathway, formal licences, organisational records, and intellectual property.

01

Scientific Foundation

Why multidimensional assessment, screening boundaries, risk stratification, and professional oversight matter.

Explore the scientific model 02

Research & Publications

Published papers, author proofs, working manuscripts, and internal evidence records shown by status.

Review the evidence library 03

Validation Programme

The progression from development and feasibility to psychometric and clinical comparison work.

Follow the programme 04

Regulatory Licences

CDSCO Form MD-5 and the earlier Form MD-13 authorisation, with intended-use limits stated plainly.

See regulatory status 05

Registrations & Certifications

Corporate incorporation, Startup India recognition, nonprofit records, and government enrolments.

View organisational records 06

Intellectual Property

MASS copyright registration and the current, accurately described PCT patent-application position.

Understand the IP position

Public evidence standard

What we will say—and what we will not say

Strong validation communication is specific about the source, status, population, product version, and limits of every claim.

Use

Precise, reviewable language

  • Published, author proof, working manuscript, or internal record
  • Screening and referral support—not autonomous diagnosis
  • CDSCO Class B licence with the authorised intended use
  • PCT international patent application—not an international patent grant
Avoid

Claims that collapse important distinctions

  • Adding overlapping study cohorts into one inflated participant total
  • Calling every archive document a publication
  • Presenting incorporation or startup recognition as clinical validation
  • Describing a pending application as a granted patent

Start with the science

See the principles behind the assessment and referral model.

Open Scientific Foundation